Sign Up
Existing User
Physician Login
  • About Us
    • Leadership
    • Board of Directors
    • Clinical Advisors
    • News & Media
    • Contact Us
    • Stratum
  • DermTech Melanoma Test
    • Overview
    • Resources
    • How To Use
  • Resources
    • Clinician Resources
    • Patient Resources
    • Testimonials
  • Publications
Forbes | Health Tech Company Hopes To Transform Skin Cancer Testing In America With A Sticker

Forbes | Health Tech Company Hopes To Transform Skin Cancer Testing In America With A Sticker

Aug 30, 2022 | Media Coverage

FOX 5’s The LOCAList SD | Quick, painless way to detect melanoma

FOX 5’s The LOCAList SD | Quick, painless way to detect melanoma

Aug 15, 2022 | Media Coverage

TODAY | Melanoma detection and diagnosis: How to spot the warning signs

TODAY | Melanoma detection and diagnosis: How to spot the warning signs

May 2, 2022 | Media Coverage

FOX 5’s The LOCAList SD | Quick, painless way to detect melanoma

FOX 5 San Diego | Foundation launched in honor of Vista firefighter who lost battle with melanoma

May 2, 2022 | Media Coverage

Practical Dermatology | Currents: Smart Approaches to Skin Cancer

Practical Dermatology | Currents: Smart Approaches to Skin Cancer

Apr 19, 2022 | Media Coverage

FOX 5’s The LOCAList SD | Quick, painless way to detect melanoma

FOX 5’s The LOCAList SD | DermTech shares new technology that can detect skin cancer

Feb 25, 2022 | Media Coverage

←123

DermTech, LLC
12340 El Camino Real
San Diego, CA 92130
Ph: (858) 450-4222
Fax: (858) 200-3877
Toll Free: (866) 450-4223

  • Follow
  • Follow
  • Follow

Company

About Us
Leadership
Board of Directors
Legal Counsel
Clinical Advisors
News & Media
Contact Us

DermTech Melanoma Test

Overview
Resources
How To Use
Publications

Physician Portal

  • Login
  • Register

Sign up for the latest news!

By submitting this form, you agree to receive communications from DermTech, LLC.

This test is a physician-ordered laboratory-developed test and is regulated under the Clinical Laboratory Improvement Amendment (CLIA). The DermTech laboratory, which developed and validated this test, is qualified to perform high-complexity testing in accordance with CLIA standards, is accredited by the Joint Commission, and is permitted by the New York State Department of Health. False positive and false negative results may occur. Samples of insufficient quantity or quality may not produce a result.

DermTech takes patient safety and the quality of laboratory services very seriously. If you have a patient safety or quality concern related to the DermTech Clinical Laboratory, we encourage you to share this concern directly with laboratory leadership by calling (858) 450-4222, or by submitting an email to operations@dermtech.com. 

The DermTech Clinical Laboratory is accredited by The Joint Commission. In addition to submitting your patient safety or quality concerns directly to DermTech leadership, you may also report a patient safety concern or file a complaint through The Joint Commission website:

https://www.jointcommission.org/resources/patient-safety-topics/report-a-patient-safety-concern-or-complaint/

Alternatively, concerns and complaints may be mailed to The Joint Commission:

Office of Quality and Patient Safety
The Joint Commission
One Renaissance Boulevard
Oakbrook Terrace, Illinois 60181

If you prefer to submit your concern or complaint via mail, please follow these tips for what to include in your report.

Copyright © 2025 DermTech. All Rights Reserved. | Lab Licenses | Patents | Risk Information | Notice of Patient Privacy Practices | Terms of Use | Privacy Policy | Instructions for Use